Skip to main content

Featured

5 Things to Know Today: US Import Ban, Oil Tops $100, TSX Slides, ECB Hikes

  September 10, 2026 A big trade-war escalation, a return of $100 oil, a wobbly TSX, and a central bank on the move overseas — here's what's moving markets and your wallet this morning. 1. Washington Bans Canadian Alcohol, Dairy Ingredients and Motorcycles The trade war jumped up another notch Tuesday night. The White House issued executive orders banning imports of most Canadian alcoholic beverages — beer, wine, whisky, vodka, rum, tequila and more — along with whey protein, molasses and non-alcoholic beer, plus Canadian-made motorcycles. The bans take effect September 29. Several cheese products were added to the existing 50% tariff list rather than banned outright, and Trump's threat to raise auto tariffs from 25% to 50% on January 1 remains on the table. The move follows Canada's own $27.6-billion retaliation tariffs, which took effect at midnight Tuesday. Trade Minister Dominic LeBlanc called the U.S. measures "unjustified." What it means for you: This m...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment